Innovative, Differentiated Generics To Lead Merck Into EMs, Says Merck EM President Kevin Ali; Prefer Partners Over Buyouts

MUMBAI - Merck & Co.'s President for Emerging Markets Kevin Ali likes to understand the "ground feel" of a company, says a senior company executive at its India affiliate MSD, and that need to see things in person may have brought the busy executive trotting back to India in less than three months of signing a "transformative deal" with Sun Pharmaceutical Industries Ltd